Dr Fiona Murphy

Lecturer

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

My research focuses on identifying the hazards to human health posed by inhalation exposure to aerosolised particles and nanomaterials. Recent focus is on the development of physiologically-relevant in vitro models to reduce the reliance on rodent models for hazard assessment of novel materials and to improve our understanding of the underlying mechanism of particle-related lung disease.

Back to staff profile

Publications

Evaluation of a bioprinted 3D airway tissue model for toxicity testing of nanomaterials; pathway to integration into a tiered testing strategy for hazard assessment to support safety-by-design
Lee Yunji, McAllister Katie, Lee Hwa-Rim, Jung Sungjune, Murphy Fiona
Nano Today Vol 61 (2025)
https://doi.org/10.1016/j.nantod.2025.102655
Humanising nanotoxicology : replacement of animal-derived products in the application of integrated approaches to testing and assessment of nanomaterial inhalation hazard
Fraser Roma, Campbell Keira, Pokorski Pawel, Mackinnon Eve, McAllister Katie, Neves Karla B, Murphy Fiona
Frontiers in Bioengineering and Biotechnology Vol 13 (2025)
https://doi.org/10.3389/fbioe.2025.1526808
Asbestos and disease genomics : is mesothelioma a genomic paradigm?
Jaurand Marie-Claude, Murphy Fiona, Felley-Bosco Emanuela
Frontiers in Toxicology Vol 6 (2025)
https://doi.org/10.3389/ftox.2024.1536344
Safe-by-design assessment of an SiO2@ZnO multi-component nanomaterial used in construction
Brunelli A, Serrano-Lotina A, Bañares M A, Alcolea-Rodriguez V, Blosi M, Costa A, Ortelli S, Peijnenburg W, Fito C, Fernandez E G, Hermosilla J S, Soeteman-Hernández L G, Garmendia Aguirre I, Rauscher H, Murphy F, Stone V, Balbuena J, Cormano J M L, Pizzol L, Hristozov D, Marcomini A, Badetti E
Environmental Science: Nano Vol 12, pp. 762-776 (2025)
https://doi.org/10.1039/d4en00352g
Non-cyclic nucleotide EPAC1 activators suppress lipopolysaccharide-regulated gene expression, signalling and intracellular communication in differentiated macrophage-like THP-1 cells
Wiejak Jolanta, Murphy Fiona A, Barker Graeme, Maffia Pasquale, Yarwood Stephen J
Cellular Signalling Vol 124 (2024)
https://doi.org/10.1016/j.cellsig.2024.111444
Differential roles for the oxygen sensing enzymes PHD1 and PHD3 in the regulation of neutrophil metabolism and function
Watts Emily, Willison Joseph, Arienti Simone, Sadiku Pranvera, Coelho Patricia, Sanchez-Garcia Manuel, Zhang Ailiang, Murphy Fiona, Dickinson Rebecca, Mirchandani Ananda, Morrison Tyler, Lewis Amy, Vermaelen Wesley, Ghesquiere Bart, Carmeliet Peter, Mazzone Massimilliano, Maxwell Patrick, Pugh Christopher, Dockrell David, Whyte Moira, Walmsley Sarah
Wellcome Open Research Vol 8 (2024)
https://doi.org/10.12688/wellcomeopenres.19915.2

More publications

Back to staff profile

Professional Activities

SIPBS Open Doors Day
Chair
8/6/2024
NC3Rs NAMs-Net Launch
Participant
30/4/2024
MSci external examiner
Examiner
22/3/2024
Society of Toxicology
Speaker
2024
Animal Free Research UK Scientific Conference
Speaker
4/10/2023
NC3Rs Galleria mellonella worksop
Speaker
13/9/2023

More professional activities

Projects

DTP 2224 University of Strathclyde | McAllister, Katie
Murphy, Fiona (Principal Investigator) Perrie, Yvonne (Co-investigator) McAllister, Katie (Research Co-investigator)
01-Jan-2024 - 01-Jan-2028
Validation of Scinora serum-free media formulations and Xplace supplement for the development of animal-free NAMs for nanotoxicology
Murphy, Fiona (Principal Investigator)
01-Jan-2024 - 31-Jan-2025
Generation of physiologically-reelevant mesothelioma tumour spheroids using tunable hydrogel scaffolds for improved preclinical drug screening
Murphy, Fiona (Principal Investigator)
01-Jan-2024 - 31-Jan-2025
Developing the Chick Chorioallantoic Membrane (CAM) model for hazard assessment of High Aspect Ratio Nanomaterials
Murphy, Fiona (Principal Investigator)
07-Jan-2024 - 06-Jan-2025
Development of a physiologically-relevant in vitro model of the lung alveolar space, incorporating novel peptide hydrogels as biomimetic extracellular matrix scaffolds
Murphy, Fiona (Principal Investigator)
01-Jan-2023 - 30-Jan-2024
Development of a physiologically-relevant in vitro model of the lung alveolar space, incorporating novel peptide hydrogels as biomimetic extracellular matrix scaffolds
Murphy, Fiona (Principal Investigator)
01-Jan-2022 - 31-Jan-2024

More projects

Back to staff profile

Contact

Dr Fiona Murphy
Lecturer
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: f.murphy@strath.ac.uk
Tel: Unlisted